Literature DB >> 29666903

High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis.

Elena Arsiè1, Stefania Piconi2, Massimo Iavarone3, Valeria Cozzi4, Pietro Lampertico3, Dario Cattaneo4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29666903     DOI： 10.1007/s00228-018-2462-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

Review 1.  Isavuconazole: A New Option for the Management of Invasive Fungal Infections.

Authors:  Natasha N Pettit; Peggy L Carver
Journal:  Ann Pharmacother       Date:  2015-05-04       Impact factor: 3.154

2.  Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Authors:  Johan A Maertens; Issam I Raad; Kieren A Marr; Thomas F Patterson; Dimitrios P Kontoyiannis; Oliver A Cornely; Eric J Bow; Galia Rahav; Dionysios Neofytos; Mickael Aoun; John W Baddley; Michael Giladi; Werner J Heinz; Raoul Herbrecht; William Hope; Meinolf Karthaus; Dong-Gun Lee; Olivier Lortholary; Vicki A Morrison; Ilana Oren; Dominik Selleslag; Shmuel Shoham; George R Thompson; Misun Lee; Rochelle M Maher; Anne-Hortense Schmitt-Hoffmann; Bernhardt Zeiher; Andrew J Ullmann
Journal:  Lancet       Date:  2015-12-10       Impact factor: 79.321

3.  Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Authors:  Francisco M Marty; Luis Ostrosky-Zeichner; Oliver A Cornely; Kathleen M Mullane; John R Perfect; George R Thompson; George J Alangaden; Janice M Brown; David N Fredricks; Werner J Heinz; Raoul Herbrecht; Nikolai Klimko; Galina Klyasova; Johan A Maertens; Sameer R Melinkeri; Ilana Oren; Peter G Pappas; Zdeněk Ráčil; Galia Rahav; Rodrigo Santos; Stefan Schwartz; J Janne Vehreschild; Jo-Anne H Young; Ploenchan Chetchotisakd; Sutep Jaruratanasirikul; Souha S Kanj; Marc Engelhardt; Achim Kaufhold; Masanori Ito; Misun Lee; Carolyn Sasse; Rochelle M Maher; Bernhardt Zeiher; Maria J G T Vehreschild
Journal:  Lancet Infect Dis       Date:  2016-03-09       Impact factor: 25.071

Review 4.  A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.

Authors:  Kyle John Wilby
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-06       Impact factor: 2.441
  4 in total
  1 in total

Review 1.  Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Brian T Fisher
Journal:  Antimicrob Agents Chemother       Date:  2022-06-29       Impact factor: 5.938
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.